ISPE announced a world-class line-up of eight leading biotech experts as keynote presenters for the 2021 ISPE Biotechnology Virtual Conference & Workshop. Taking place 22-24 September 2021, this unparalleled fully interactive virtual event will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists and international regulators to network, share knowledge, and provide an outlook on the evolving landscape and future of biopharmaceutical manufacturing and therapies.
This year in particular, the industry rallied together to innovate at record speed and partnered in ways that were unprecedented to address not only the public health crisis brought on by the pandemic, but also to ensure patients worldwide would continue to have access to necessary therapies. This conference will help prepare biopharmaceutical professionals and their organizations for the impact of innovations in biologics that will influence their operations and shape the future.
Head of Global Quality Audit and External Engagement
Sanofi
Co-Chair
Keynote presenters will kick off day one of the conference with presentations on industry-critical topics such as regulatory aspects for advanced therapy medicinal products (ATMPs), cell and gene therapies, and COVID-19 therapies and vaccines. Then they will come together for a compelling panel discussion.
The ISPE Biotechnology Virtual Conference & Workshop is a leading interdisciplinary forum for all stakeholders of the pharmaceutical and biopharmaceutical value chain to unite and learn about the latest innovations and trends, and openly discuss practical challenges and solutions, from a technical, logistical and regulatory perspective.
Event exclusives include plant tours featuring state-of-the-art facilities and two in-depth workshops. Workshop participants will be presented with a case study and practice finding solutions with the help of trainers. Topics include control strategy, technology transfer, CMC, computer-based modeling, ATMPs, facility design, and GXP compliance.
The impact of the evolving regulatory environment and the need to ensure continued innovation and continuity in the supply chain in light of this crisis and assuring preparedness for future crises will be integrated throughout the conference agenda, panel discussions and accompanying workshops.
